File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL

Conference Paper: Increase in prescriptions for osteoporosis and reduction in hip fracture incidence in Hong Kong during 2005-2014

TitleIncrease in prescriptions for osteoporosis and reduction in hip fracture incidence in Hong Kong during 2005-2014
Authors
Issue Date2016
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/
Citation
The 21st Medical Research Conference (MRC 2016), Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 16 June 2016. In Hong Kong Medical Journal, 2016, v. 22 suppl. 1, p. 25, abstract no. 31 How to Cite?
AbstractAIM: Ageing of the population makes osteoporosis and the consequent hip fractures a growing problem. In clinical trials, drugs for osteoporosis typically halved the risk of hip fractures. Generic bisphosphonates are thought to be cost-effective in reducing fractures and subsequent complications. Therefore, we studied the trends in the prescription of drugs for osteoporosis and the incidence of hip fractures. METHODS: We used the data from 2005 to 2014 of the computerised database of the Hong Kong Hospital Authority. Hip fracture rates were adjusted to the 2006 Hong Kong population structure. RESULTS: In 2014, 84% of the drugs prescribed for osteoporosis were bisphosphonates. The annual number of bisphosphonate prescriptions increased from 3888 in 2005 to 32 389 in 2014. The age-adjusted incidence of hip fracture in women aged ≥60 years decreased from 426.6 per 100 000 people in 2005 to 276.7 per 100 000 people in 2012, and levelled off in the range between 270.5 and 281.8 per 100 000 people in 2012-2014. The hip fracture incidence in men aged ≥60 years also decreased, from 197.4 in 2005 to 142.5 per 100 000 in 2009 and levelled off in the range of 130 to 150 in 2009-2014 per 100 000. There was a significant reciprocal relationship between the number of typical hip fractures and the number of bisphosphonate prescriptions (r=0.94, P < 0.001 in both men and women). CONCLUSION: In the past decade in Hong Kong, the age-adjusted incidence of hip fractures decreased, which is associated with increased use of bisphosphonates for osteoporosis.
Persistent Identifierhttp://hdl.handle.net/10722/232475
ISSN
2015 Impact Factor: 0.887
2015 SCImago Journal Rankings: 0.279

 

DC FieldValueLanguage
dc.contributor.authorHo, KC-
dc.contributor.authorTsoi, MF-
dc.contributor.authorCheung, TT-
dc.contributor.authorCheung, CL-
dc.contributor.authorCheung, BMY-
dc.date.accessioned2016-09-20T05:30:15Z-
dc.date.available2016-09-20T05:30:15Z-
dc.date.issued2016-
dc.identifier.citationThe 21st Medical Research Conference (MRC 2016), Department of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, 16 June 2016. In Hong Kong Medical Journal, 2016, v. 22 suppl. 1, p. 25, abstract no. 31-
dc.identifier.issn1024-2708-
dc.identifier.urihttp://hdl.handle.net/10722/232475-
dc.description.abstractAIM: Ageing of the population makes osteoporosis and the consequent hip fractures a growing problem. In clinical trials, drugs for osteoporosis typically halved the risk of hip fractures. Generic bisphosphonates are thought to be cost-effective in reducing fractures and subsequent complications. Therefore, we studied the trends in the prescription of drugs for osteoporosis and the incidence of hip fractures. METHODS: We used the data from 2005 to 2014 of the computerised database of the Hong Kong Hospital Authority. Hip fracture rates were adjusted to the 2006 Hong Kong population structure. RESULTS: In 2014, 84% of the drugs prescribed for osteoporosis were bisphosphonates. The annual number of bisphosphonate prescriptions increased from 3888 in 2005 to 32 389 in 2014. The age-adjusted incidence of hip fracture in women aged ≥60 years decreased from 426.6 per 100 000 people in 2005 to 276.7 per 100 000 people in 2012, and levelled off in the range between 270.5 and 281.8 per 100 000 people in 2012-2014. The hip fracture incidence in men aged ≥60 years also decreased, from 197.4 in 2005 to 142.5 per 100 000 in 2009 and levelled off in the range of 130 to 150 in 2009-2014 per 100 000. There was a significant reciprocal relationship between the number of typical hip fractures and the number of bisphosphonate prescriptions (r=0.94, P < 0.001 in both men and women). CONCLUSION: In the past decade in Hong Kong, the age-adjusted incidence of hip fractures decreased, which is associated with increased use of bisphosphonates for osteoporosis.-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkmj.org/-
dc.relation.ispartofHong Kong Medical Journal-
dc.rightsHong Kong Medical Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.titleIncrease in prescriptions for osteoporosis and reduction in hip fracture incidence in Hong Kong during 2005-2014-
dc.typeConference_Paper-
dc.identifier.emailCheung, TT: tcheungt@hku.hk-
dc.identifier.emailCheung, CL: lung1212@hku.hk-
dc.identifier.emailCheung, BMY: mycheung@hkucc.hku.hk-
dc.identifier.authorityCheung, TT=rp01682-
dc.identifier.authorityCheung, CL=rp01749-
dc.identifier.authorityCheung, BMY=rp01321-
dc.identifier.hkuros265899-
dc.identifier.volume22-
dc.identifier.issuesuppl. 1-
dc.identifier.spage25, abstract no. 31-
dc.identifier.epage25, abstract no. 31-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats